Carmethizole
Alternative Names: NSC 602668Latest Information Update: 30 May 2001
Price :
$50 *
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antineoplastics; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 28 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)